Table 2.
Results of health-related quality of life measurement at six months in patients who had complete follow-up at twelve and twenty-four months (n = 31) or were lost to follow-up (dead = 9, no reply = 11)a
| Parameters | Complete follow-up (n = 31) |
Lost to follow-up | |
|---|---|---|---|
| Dead (n = 9) | No reply (n = 11) | ||
| EQ-5D | 0.66 (0.62 to 0.80) 0.62 |
-0.02 (-0.17 to 0.74) 0.22 |
0.55 (0.26 to 0.73) 0.51 |
| EQ-VAS | 50 (40 to 60) 51.1 |
39 (5 to 70) 36 |
60 (43 to 73) 55 |
| PF | 45 (25 to 65) 45.5 |
18 (3 to 33)* 21 |
35 (10 to 45) 34 |
| RP | 25 (0 to 75) 37.5 |
0 (0 to 25) 18 |
0 (0 to 33) 21 |
| BP | 47 (22 to 100) 53.6 |
22 (10 to 52) 35 |
41 (22 to 52) 46 |
| GH | 40 (25 to 52) 43.1 |
23 (10 to 40) 31 |
44 (30 to 67) 49 |
| VT | 45 (35 to 55) 47.0 |
30 (15 to 48) 34 |
50 (35 to 60) 50 |
| SF | 75 (38 to 100) 68.2 |
38 (13-63)* 38 |
50 (38 to 88) 57 |
| RE | 83 (0 to 100) 58.3 |
0 (0 to 42) 23 |
83 (0 to 100) 60 |
| MH | 68 (48 to 88) 66.0 |
58 (24 to 90) 56 |
72 (40 to 80) 60 |
aBP, bodily pain; EQ-5D, EuroQoL 5 Dimension; EQ-VAS, EuroQoL Visual Analogue Scale; GH, general health; MH, mental health; PF, physical functioning ; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality. Values are medians (interquartile ranges) and means. *P < 0.05 compared to patients with complete follow-up.